Key result
Genetic liability to MDD linked to ~26% greater T2D risk and increased CAD risk.
Why the study?
Observational studies have shown a bidirectional association between major depressive disorder and cardiometabolic diseases, but causal associations remained unproven.
Does genetic liability to major depressive disorder increase the risk of type 2 diabetes, coronary artery disease, and heart failure?
Observational
Does genetic liability to major depressive disorder increase the risk of type 2 diabetes, coronary artery disease, and heart failure?
Effect estimate: OR 1.26 (95% CI 1.10, 1.43)
p-value: p=6x10^-4
This Mendelian randomisation study provides evidence that major depressive disorder is a potential causal risk factor for type 2 diabetes and coronary artery disease.
Supports MDD as potential causal factor for T2D/CAD; leaves open whether treatment reduces risk.
Aims/hypothesis Observational studies have shown a bidirectional association between major depressive disorder (MDD) and cardiometabolic diseases. We conducted a two-sample bidirectional Mendelian randomisation (MR) study to assess the causal associations of MDD with type 2 diabetes, coronary artery disease (CAD) and heart failure and vice versa. Methods We extracted summary-level data for MDD, type 2 diabetes, CAD and heart failure from corresponding published large genome-wide association studies of individuals mainly of European-descent. In total, 96 SNPs for MDD, 202 SNPs for type 2 diabetes, 44 SNPs for CAD and 12 SNPs for heart failure were proposed as instrumental variables at the genome-wide significance level ( p < 5 × 10 −8 ). The random-effects inverse-variance weighted method was used for the main analyses. Results Genetic liability to MDD was significantly associated with type 2 diabetes and CAD at the Bonferroni-corrected significance level. The ORs of type 2 diabetes and CAD were respectively 1.26 (95% CI 1.10, 1.43; p = 6 × 10 −4 ) and 1.16 (95% CI 1.05, 1.29; p = 0.0047) per one-unit increase in log e odds of MDD. There was a suggestive association between MDD and heart failure (OR 1.11 [95% CI 1.01, 1.21]; p = 0.033). We found limited evidence supporting causal effects of cardiometabolic diseases on MDD risk in the reverse MR analyses. Conclusions/interpretation The present study strengthened the evidence that MDD is a potential risk factor for type 2 diabetes and CAD. Whether MDD is causally related to heart failure needs further study. Data availability All data included in this study were uploaded as supplements and are also publicly available through published GWASs and open GWAS datasets (UK Biobank, 23andMe and Psychiatric Genomics: https://datashare.is.ed.ac.uk/handle/10283/3203; DIAGRAM: http://diagram-consortium.org/downloads.html; CARDIoGRAMplusCD4: www.cardiogramplusc4d.org/; HERMES: http://www.kp4cd.org/datasets/mi ).
No takes yet. Share an insight, caveat, or question.
Tang et al. (2020) conducted an observational in Major depressive disorder, type 2 diabetes, coronary artery disease, heart failure. Genetic liability to major depressive disorder was evaluated on Type 2 diabetes (OR 1.26, 95% CI 1.10, 1.43, p=6x10^-4). Genetic liability to major depressive disorder significantly increased the risk of type 2 diabetes (OR 1.26) and coronary artery disease (OR 1.16).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: